ADAPTIVE BIOTECHNOLOGIES CORPORATION Unrealized Gain (Loss) on Investments
ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) reported Unrealized Gain (Loss) on Investments of $0 for the 6-month period ending 2020-06-30, per its 10-Q filed 2020-08-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnInvestments · last filed 2020-08-10
- 2020-06-30: Unrealized Gain (Loss) on Investments 6 month $0.00.
| Period end | Unrealized Gain (Loss) on Investments 6 month |
|---|---|
| 2020-06-30 | $0.00 10-Q · filed 2020-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |